Severn Pathology (North Bristol NHS Trust Pathology Sciences and UKHSA Bristol Laboratory) is committed to setting and achieving high quality standards that meet the needs and requirements of its users.
Severn Pathology will:
- Operate a quality management system to integrate the organisation, procedures, processes, and resources, and ensure this is continually reviewed for fitness for purpose.
- Ensure that personnel comply with the policies of North Bristol NHS Trust and UK Health Security Agency as required.
- Establish and review quality objectives and plans to implement this quality policy and to achieve continual quality improvement.
- Ensure that all personnel are familiar with this quality policy and comply with the quality manual and all procedures relevant to their work to ensure user satisfaction.
- Encourage good communication between all staff.
- Commit to the health, safety, and welfare of its staff. Visitors to the department will be treated with respect, and due consideration will be given to their safety while on site.
- Commit to comply with relevant environmental legislation.
- Uphold professional values and be committed to good professional practice and conduct.
Severn Pathology will comply with the requirements of all relevant regulatory bodies, population screening programmes, the Data Protection Act 2018, and ISO 15189; and is committed to:
- The treatment of patients, samples and remains with due care and respect.
- Identification and mitigation of actual and potential risks to patient care.
- Staff recruitment, training, development and retention at all levels to provide a full and effective service to its users.
- The proper procurement and maintenance of such equipment and other resources as are needed for the provision of the service.
- The collection, transport and handling of all specimens in such a way as to ensure the correct performance of laboratory examinations.
- The use of examination procedures that will ensure the acceptable quality of all tests performed and are fit for their intended use.
- Reporting results of examinations in ways which are timely, confidential, accurate and clinically useful.
- The assessment of patient and user satisfaction, in addition to internal audit and external quality assessment, as part of its commitment to continual quality improvement.
- Providing a comprehensive diagnostic service for Pathology, incorporating a number of national reference laboratories.
- The safe and timely provision of blood and blood products, initiation of recall and the external reporting (SABRE scheme) of transfusion related incidents.
Signed by:
Mr D. Fisher, Pathology Services Director
Mr J. Steer, UK Health Security Agency Regional Head of Operations